Aussie firm Phebra inaugurates manufacturing unit
Australia | News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2013
Singapore: Sydney-based pharmaceutical company Phebra has inaugurated its $25 million manufacturing facilities at Lane C...Read more
Phospagenics, Nippon Zoki to develop pain drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2013
Singapore: Australian drug delivery technology company Phosphagenics has extended its collaboration with its high calib...Read more
DSM Pharma, DecImmune sign antibody deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: Australia's DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has signed an ...Read more
Flu vaccine reduces heart attack risk
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Aug, 2013
Singapore: Regular shots of influenza injections have the added benefit of reducing the risk of heart attacks in people ...Read more
M&A activity slows down in APAC
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2012
In 2011, the number of mergers and acquisitions in the life sciences field of Asia Pacific witnessed a fall. An indepen...Read more
Viralytics melanoma study shows +ve results
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2013
Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavat...Read more
Stem cell industry has substantial growth potential
Australia | Analysis | By Piyusha Chatterjee | 3 Comment | 31 Jan, 2013
The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...Read more
Prima BioMed announces changes in senior management
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 May, 2012
Singapore: Australian firm Prima BioMed suggested several changes to its senior management and its board of directors, w...Read more
Genetic diagnostics usher in a new era in healthcare
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2012
Thanks to the Human Genome Project, scientists now have a set of tools that can be readily used to understand the comple...Read more
Melbourne firm, Optimer sign deal for DIFICID
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2012
Singapore: A new therapy to treat a common hospital superbug infection Clostridium difficile will soon be available to A...Read more
Aussie's CardioCel gets US approval
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2014
Singapore: Australia based Admedus has received FDA clearance to market CardioCel in the US. CardioCel is the group's l...Read more
Biolife HER-Vaxx B cell peptide vaccine hailed
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2013
Singapore: Biolife Science's strategy of targeting the tumour-associated antigen HER-2/NEU has been the focus of a recen...Read more
Asia biologics manufacturers face the 'quality challenge'
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012
Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy...Read more
Biota shareholders' meet on Sept 25 for merger with Nabi
Australia | News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2012
Singapore: The Supreme Court of Victoria, Australia, has ordered a meeting of Biota Holdings shareholders to consider an...Read more
Viralytics presents +ve results of phase II Cavatak trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2013
Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...Read more
Breakthrough in prostate cancer research
Australia | News | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
Singapore: Researchers in Monash University, Australia, have found prostate cancer cells that survive androgen withdrawa...Read more
Competition intensifies for type 2 diabetes drugs
Australia | Analysis | By BioSpectrum Bureau | 1 Comment | 28 Aug, 2013
Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...Read more
Digital healthcare, the next big thing
Australia | Opinion | By Nandita Singh | 0 Comment | 07 Aug, 2013
A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies w...Read more